Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

1.3K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.3K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

1.2K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.2K
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

6.3K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
6.3K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

829
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
829
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

4.1K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

558
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
558

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allopurinol and Chronic Kidney Disease.

The New England journal of medicine·2020
Same author

UWB-Based Self-Localization Strategies: A Novel ICP-Based Method and a Comparative Assessment for Noisy-Ranges-Prone Environments.

Sensors (Basel, Switzerland)·2020
Same author

Views of Farmers and Industrial Entrepreneurs on The Iberian Pig Quality Standard: An In-Depth Interview Research Study.

Animals : an open access journal from MDPI·2020
Same author

IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.

Biomolecules·2020
Same author

Effect of Coffee Consumption on Renal Outcome: A Systematic Review and Meta-Analysis of Clinical Studies.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation·2020
Same author

The effect of energy restriction on development and progression of chronic kidney disease: review of the current evidence.

The British journal of nutrition·2020

Related Experiment Video

Updated: Mar 5, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

2.4K

A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis

Ricardo Villa-Bellosta1,2,3, Laura Rodriguez-Osorio1,2,4, Sebastian Mas1,2,3

  • 1Servicio de Nefrología, Fundación Jiménez Díaz, Madrid, España.

Plos One
|March 25, 2017
PubMed
Summary
This summary is machine-generated.

In hemodialysis patients, a decrease in parathyroid hormone (PTH) levels over one year was linked to increased mortality risk. Conversely, stable or increasing PTH levels were associated with better survival rates.

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

15.4K

Related Experiment Videos

Last Updated: Mar 5, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

2.4K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

15.4K

Area of Science:

  • Nephrology
  • Endocrinology
  • Clinical Medicine

Background:

  • Dialysis patients face significantly higher mortality rates compared to the general population.
  • Serum parathyroid hormone (PTH) levels, and their changes over time (ΔPTH), are known predictors of mortality in dialysis patients.

Purpose of the Study:

  • To investigate the association between the change in intact parathyroid hormone (iPTH) levels over one year and subsequent mortality in prevalent hemodialysis patients.
  • To determine if baseline iPTH levels or the change in iPTH (ΔiPTH) is a stronger predictor of mortality.

Main Methods:

  • A prospective cohort study involving 115 prevalent hemodialysis patients from a single center.
  • Patients had median baseline iPTH levels within guideline recommendations.
  • ΔiPTH was calculated over one year, and mortality was tracked over the subsequent year.

Main Results:

  • A decrease in ΔiPTH was significantly associated with higher mortality.
  • Patients who survived showed a substantial increase in ΔiPTH, while those who died had lower or negative ΔiPTH.
  • Logistic regression indicated that ΔiPTH was a significant predictor of mortality (OR 0.998, p = 0.038).
  • Mortality risk was substantially reduced in patients with increasing ΔiPTH compared to those with decreasing ΔiPTH.

Conclusions:

  • In hemodialysis patients with baseline iPTH within recommended ranges, a decrease in ΔiPTH is linked to increased mortality.
  • These findings challenge current clinical practice and suggest a need for further research into the mechanisms and therapeutic implications of PTH level changes.